Benefits of Conversion Surgery after Multimodal Treatment for Unresectable Pancreatic Ductal Adenocarcinoma.
Hiroaki YanagimotoSohei SatoiTomohisa YamamotoSo YamakiSatoshi HirookaMasaya KotsukaHironori RyotaMitsuaki IshidaYoichi MatsuiMitsugu SekimotoPublished in: Cancers (2020)
Conversion surgery offers benefits in terms of increase survival for initially UR-PDAC for patients who responded favorably to chemo(radiation)therapy when combined with postoperative adjuvant chemotherapy.